Literature DB >> 10613997

Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents.

F H Jafary1, C D Kimmelstiel.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10613997     DOI: 10.1023/a:1018770914974

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  53 in total

Review 1.  Pharmacology of ticlopidine: a review.

Authors:  G Defreyn; A Bernat; D Delebassee; J P Maffrand
Journal:  Semin Thromb Hemost       Date:  1989-04       Impact factor: 4.180

2.  Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty.

Authors:  N J Lembo; A J Black; G S Roubin; J R Wilentz; L H Mufson; J S Douglas; S B King
Journal:  Am J Cardiol       Date:  1990-02-15       Impact factor: 2.778

Review 3.  Molecular mechanisms of platelet aggregation.

Authors:  L Leung; R Nachman
Journal:  Annu Rev Med       Date:  1986       Impact factor: 13.739

4.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

5.  [Ticlopidine may prevent subtotal or total occlusion of dilated lesions after percutaneous coronary angioplasty].

Authors:  H Kitazume; Y Ageishi; T Iwama; I Kubo; A Suzuki
Journal:  J Cardiol       Date:  1993       Impact factor: 3.159

6.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Authors:  M B Leon; D S Baim; J J Popma; P C Gordon; D E Cutlip; K K Ho; A Giambartolomei; D J Diver; D M Lasorda; D O Williams; S J Pocock; R E Kuntz
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

Review 7.  Clinical pharmacokinetics of ticlopidine.

Authors:  J P Desager
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

8.  Platelet activation during coronary angioplasty in humans.

Authors:  C M Gasperetti; S L Gonias; L W Gimple; E R Powers
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

9.  Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study.

Authors:  R A Schatz; D S Baim; M Leon; S G Ellis; S Goldberg; J W Hirshfeld; M W Cleman; H S Cabin; C Walker; J Stagg
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

10.  The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit.

Authors:  J M Herbert; F Dol; A Bernat; R Falotico; A Lalé; P Savi
Journal:  Thromb Haemost       Date:  1998-09       Impact factor: 5.249

View more
  1 in total

Review 1.  Antiplatelet therapy in interventional cardiology: II. Glycoprotein IIb/IIIa inhibitors.

Authors:  F H Jafary; C D Kimmelstiel
Journal:  J Thromb Thrombolysis       Date:  2000-02       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.